Oncology & Cancer

In a comprehensive study, researchers from the Department of Epidemiology at the Faculty of Medicine at the University of Augsburg have provided reliable evidence for a link between chronic inflammatory diseases and the development of tumors in the digestive tract. The results were recently published in eClinicalMedicine.

Despite increasing evidence linking alcohol consumption to cancer, little is known about the biological mechanisms behind the association.

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer, two of the most difficult-to-treat malignancies, according to a study led in part by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

There is growing recognition of the important role that social needs, such as access to food, housing, and transportation, play in health care. Research has demonstrated their impact on physical and emotional well-being in a number of patient populations.

Researchers at City of Hope have published a new study which found that some survivors of childhood cancer are more at risk for serious health issues as they grow older, including new cancers and chronic conditions like heart disease.

Scientists at Tsinghua University have developed a method to grow kidney tumors in the lab using cells from real patients, offering a potential new tool in the fight against renal cancer.

Cancer of the voice box or larynx is an important public health burden. In 2021, there were an estimated 1.1 million cases of laryngeal cancer worldwide, and approximately 100,000 people died from it. Risk factors include smoking, alcohol abuse, and infection with human papillomavirus. The prognosis for laryngeal cancer ranges from 35% to 78% survival over five years when treated, depending on the tumor’s stage and its location within the voice box.

A research team at National Taiwan University has developed a new stem cell-based vaccine that could help prevent and treat colorectal cancer.

University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a “two-in-one” molecule that can simultaneously turn off two notoriously difficult-to-target cancer-related genes, KRAS and MYC, as well as directly deliver drugs to tumors that express these genes. This advance holds special promise for treating cancers that have been historically challenging to treat.

In a small new study, a handheld saliva-sampling device successfully detected breast cancer 100% of the time, researchers said.